Brain+ announces Investor Webinar following strong Q4 with product launch and successful capital raise
Copenhagen, Denmark, December 22, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcementsHighlights of Q4 2022 · Successfully raised 6.4 million DKK in new capital from 82% warrant exercise · Advanced the first dementia product, CST-Therapist Companion towards commercialization · Started the introduction of Danish version to municipal dementia clinics in Denmark · Started a 3-month